AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00833014 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dynamic Annuloplasty Ring (with option to adjust off-pump)
Description: Annuloplasty device repair of mitral valve regurgitation with option to adjust device post implant.
Study NCT02844894 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Study NCT02844894 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esmolol
Study NCT02844894 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: normal saline
Study NCT01031017 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: progesterone
Description: ovules, 200mg per vagina, once a day from 18 weeks
Study NCT01031017 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo
Study NCT03942367 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active Device (vPatch)
Description: Electrical stimulation inducing motor response at the pelvic-floor muscles. Stimulation will be delivered by vPatch device configured to motor intensity.
Study NCT03942367 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Device (vPatch)
Description: Electrical stimulation inducing sensory response at the perineum.Stimulation will be delivered by vPatch device configured to sensory intensity.
Study NCT02306421 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: RPH with the simplified Milligan-Morgan
Description: RPH is a new therapy for hemorrhoid following the improvement of rubber band ligation. The treatment principle is: shrinkage of mucous membrane after the ligation, lift of anal cushion, the local inflammatory response resulting in adhesion of mucosa and submucosa and shallow muscle layer, anal cushion fixing to a higher position, at the same time by using the elastic contraction of automatic elastic line partly blocking blood supply of Internal hemorrhoids or reducing venous stasis, decreasing congestion hypertrophy of hemorrhoids. Simplified Milligan-Morgan is a surgical option which was improved and developed by Professor He,well-known traditional Chinese doctor from Hunan province, based on Milligan-Morgan in 1971.The operation method is simple, the operation time is shortened.
Study NCT01514851 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Calcium carbonate
Study NCT02768597 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ReUnion System with a Large-Diameter Glenosphere +2 mm offset
Description: Primary Reverse Shoulder Arthroplasty using the ReUnion System with a Large-Diameter Glenosphere +2 mm offset
Study NCT02768597 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ReUnion System with a Small-Diameter Glenosphere +2 mm offset
Description: Primary Reverse Shoulder Arthroplasty using the ReUnion System with a Small-Diameter Glenosphere +2 mm offset
Study NCT02768597 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ReUnion System with a Large-Diameter Glenosphere +6 mm offset
Description: Primary Reverse Shoulder Arthroplasty using the ReUnion System with a Large-Diameter Glenosphere +6 mm offset
Study NCT02768597 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ReUnion System with a Small-Diameter Glenosphere +6 mm offset
Description: Primary Reverse Shoulder Arthroplasty using the ReUnion System with a Small-Diameter Glenosphere +6 mm offset
Study NCT02784743 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ''albendazole'' and ''ivermectin''
Description: annual single dose administration of albendazole 400mg and ivermectin 150ug/kg of weight (according to the height)
Study NCT02968706 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High Flow Nasal Cannula
Description: Heated humidified high flow oxygen of 50 L/min at FiO2 of 40%
Study NCT02968706 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Nasal Cannula
Description: Supplemental oxygen of 2-5 L/min
Study NCT02968706 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Patient satisfaction questionnaire
Description: Questionnaire
Study NCT02968706 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Patient satisfaction questionnaire
Description: Questionnaire
Study NCT01476683 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Racecadotril
Description: Film-coated tablet
Study NCT01476683 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Racecadotril
Description: Racecadotril Powder Blend
Study NCT01476683 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Racecadotril
Description: Marketed Capsule
Study NCT01476683 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Racecadotril
Description: Marketed Film-coated Tablet
Study NCT02306421 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PPH with the simplified Milligan-Morgan
Description: According to anal cushion down theory of the formation of hemorrhoids, the Italy scholar Longo pioneered a new method for the treatment of circular prolapsed internal hemorrhoids In 1998.Its principle is resection of lower rectal mucosa and submucosa of the intestinal wall tissue in the ring above the hemorrhoids through surgical staples,anastomosis of the proximal and distal mucosa , lifting and fixing down anal cushion, recovering to the normal anatomical position.Simplified Milligan-Morgan is a surgical option which was improved and developed by Professor He,well-known traditional Chinese doctor from Hunan province, based on Milligan-Morgan in 1971.The operation method is simple, the operation time is shortened.
Study NCT02306421 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: RPH
Description: RPH is a new therapy for hemorrhoid following the improvement of rubber band ligation.The treatment principle is: shrinkage of mucous membrane after the ligation, lift of anal cushion, the local inflammatory response resulting in adhesion of mucosa and submucosa and shallow muscle layer , anal cushion fixing to a higher position, at the same time by using the elastic contraction of automatic elastic line partly blocking blood supply of Internal hemorrhoids or reducing venous stasis, decreasing congestion hypertrophy of hemorrhoids , making hemorrhoidal lump shrink, thus eliminating bleeding and prolapse symptoms of hemorrhoid.It is suitable for internal hemorrhoids in every period and internal hemorrhoids part of mixed hemorrhoid.
Study NCT02306421 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PPH
Description: According to anal cushion down theory of the formation of hemorrhoids, the Italy scholar Longo pioneered a new method for the treatment of circular prolapsed internal hemorrhoids In 1998.Its principle is resection of lower rectal mucosa and submucosa of the intestinal wall tissue in the ring above the hemorrhoids through surgical staples,anastomosis of the proximal and distal mucosa , lifting and fixing down anal cushion, recovering to the normal anatomical position
Study NCT00883298 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: temozolomide and bevacizumab
Description: oral temozolomide 100 mg/m2 days 1-5 \& 15-19 every 28-day cycle plus intravenous bevacizumab 10 mg/kg days 1 \& 5 every 28-day cycle
Study NCT02607787 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: The exercise programme aims to gradually increase participants physical activity levels so that they start achieving the recommended levels of at least 150 minutes moderate intensity aerobic activity per week and strengthening exercise for all major muscle groups at least twice per week.
Study NCT02607787 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: The control group will receive usual care whilst attending for the same 4 visits as the intervention group and have the same outcome measures tested. They will however receive the intervention information on their last visit.
Study NCT01392703 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Dasatinib as tablets
Description: 2 50-mg tablets plus 240 mL noncarbonated, nonrefrigerated water. Oral, single dose, 1 day
Study NCT01392703 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Dasatinib as liquid
Description: 100 mg administered as 10 mL of liquid drug (10 mg/mL) plus 230 mL noncarbonated, nonrefrigerated water. Oral, single dose, 1 day
Study NCT01392703 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Dasatinib as dispersed tablets
Description: 2 50-mg dispersed tablets in 30 mL of 100% orange juice followed by 15 mL of orange juice plus 195 mL noncarbonated, nonrefrigerated water. Liquid (oral solution), single dose, 1 day.
Study NCT00470197 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: alvocidib
Description: Given IV
Study NCT00470197 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cytarabine
Description: Given IV
Study NCT00470197 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mitoxantrone hydrochloride
Description: Given IV
Study NCT00470197 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacological study
Description: Correlative study
Study NCT05201053 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Exploratory for different markers
Description: Test biomarkers for development of mild, moderate or severe disease
Study NCT03721705 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Renew NCP-5
Description: Treatment will be given 3-5 times a week for a total of 35 treatments over 12 weeks.
Study NCT03721705 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Renew NCP-5
Description: Treatment will be given 3-5 times a week for a total of 35 treatments over 12 weeks.
Study NCT03078335 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Glove based care
Description: Described in Experimental Arm: Glove based care
Study NCT02306421 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Milligan-Morgan
Description: Milligan-Morgan surgery ,created in 1937 by Milligan etc,whose essence is to excise hemorrhoids of increasing prolapse in anatomy has good curative effect, low recurrence.It is currently the most common clinical surgery.
Study NCT03067259 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Exposure Group
Description: Surgeries of high or low impact. They could be local , regional o general anesthesia; sedation or a combination of both.
Study NCT01967979 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RO5285119
Description: Single dose, alone and after repeated administration of itraconazole or fluoxetine
Study NCT01967979 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fluoxetine
Description: Multiple doses
Study NCT01967979 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: itraconazole
Description: Multiple doses
Study NCT02469168 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Recell
Description: ReCell Treatment over wound pretreated with INTEGRA™ MBWM Wound Matrix
Study NCT02469168 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Standard meshed split thickness skin graft over wound pretreated with INTEGRA™ MBWM Wound Matrix
Study NCT00433017 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Verteporfin Photodynamic Therapy
Description: After a 10-minute intravenous infusion of verteporfin at a dose of 6 mg/m\^2 body surface area, verteporfin was activated by light application of 50 J/cm\^2 to the study eye, begun 15 minutes after the start of the infusion.
Study NCT00433017 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ranibizumab
Description: Ranibizumab 0.5 mg (0.05 mL of 10 mg/mL solution for injection) administered as an intravitreal injection
Study NCT03078335 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care - Hand Hygiene
Description: Hand Hygiene - hand washing with soap and water, or alcohol based hand rub
Study NCT04338412 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ProSeal-LMA™
Description: It is a second generation LMA that is commonly used among all other LMAs
Study NCT03585088 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: surgical pleth index
Description: All patients applied surgical pleth index after recovery of spontaneous breathing at the time of peritoneum and skin closure under Bispectral index score \<=60.
Study NCT01843777 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard-of-Care
Description: the standard of care in audiologic practice
Study NCT01843777 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treatment
Description: motivational interviewing
Study NCT01746147 — intervention group
Intervention type: OTHER
Intervention: No intervention and study treatment
Study NCT03721172 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apremilast
Description: Apremilast, oral, twice daily
Study NCT03721172 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo, oral, twice daily
Study NCT02562157 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: HYALURONIQUE ACIDE
Description: Intradermal delivery of fractional CO2 laser-assisted hyaluronic acid in facial skin contouring
Study NCT00420784 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telaprevir
Description: tablet
Study NCT00420784 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ribavirin
Description: tablet
Study NCT00420784 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ribavirin
Description: tablet
Study NCT00420784 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Pegylated Interferon Alfa 2a
Description: Solution for injection
Study NCT00420784 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pegylated Interferon Alfa 2a
Description: Solution for injection
Study NCT00420784 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Matching Placebo
Description: Tablet
Study NCT03859817 — intervention group
Intervention type: OTHER
Intervention: Comparison of eGFR values and ketonemia in diabetic patients
Description: To verify if there is a correlation between the level of ketones and an alteration of the renal function in the diabetic patient, the values of the prognostic markers indicated in the protocol and the data downloaded by the glucometers will be evaluated in addition to the blood tests of the patients
Study NCT04627051 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Atherectomy and balloon angioplasty
Description: Atherectomy and balloon angioplasty of arterial-venous graft stenosis
Study NCT04205357 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Sulfasalazine
Description: Sulfasalazine combined with stereotactic radiosurgery
Study NCT00325598 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Partial Breast Irradiation (PBI)
Study NCT00502502 — intervention group
Intervention type: BEHAVIORAL
Intervention: Questionnaire
Description: Weekly questionnaires lasting about 30 minutes.
Study NCT00607672 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT00607672 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ramipril
Description: Ramipril 2.5mg day 1 and 2 and then 5mg/d thereafter
Study NCT00607672 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Candesartan
Description: Candesartan 16mg/d
Study NCT01673789 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Stem Cell Educator
Description: For the treatment, commonly the left (or right) median cubital vein, a patient's blood is passed through a Blood Cell Separator that isolates the lymphocytes from the blood according to the recommended protocol by manufacture; consequently, the collected lymphocytes were transferred into the Stem Cell Educator and treated by CB-SC; after that, the educated cells return the blood back to the patient via a dorsal vein of hand. During the MCS+ collection, the whole blood flow rate was maintained at 35 mL/min. The whole procedure was scheduled for 8 \~ 9 hrs.
Study NCT01013545 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: JAE Intervention
Description: The overall goal in each session will be for the caregiver-child dyad to be in a state of supported or coordinated joint engagement. In this state the child is aware of the other's activity, and may actively coordinate their attention between an object/toy and the caregiver. The interventionist will coach the caregiver and child while they engage in play routines established through collaboration between caregiver and interventionist.
Study NCT02339545 — intervention group
Intervention type: DEVICE
Intervention: Coronary Orbital Atherectomy plus Stenting
Study NCT03629470 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Conservative Treatment
Description: Range of motion exercises, medication and activity modification.
Study NCT03629470 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Conservative Treatment
Description: Range of motion exercises, medication and activity modification.
Study NCT03629470 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nerve Gliding Exercises
Description: Taught by occupational therapist. These exercises involve motions of the wrist, arm and neck. Subjects will be instructed to perform exercises regularly following the occupational therapists' protocol
Study NCT01796054 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stress Free Now online program
Description: Stress Free Now is an online stress reduction program. Participants will log into online program, read and practice daily and weekly activities.
Study NCT01796054 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group support session
Description: Participants will meet weekly for group support session to review online lessons and relaxation therapies.
Study NCT06544603 — intervention group
Intervention type: DEVICE
Intervention: Multiwave Locked System (MLS) laser
Description: Laser probe directly contacts with skin of the all the acupoints. The probe was fixed on each point for 1 min. In this study, the laser acupuncture used have wavelength of 808 nm and 905nm, 1.2 W power (808nm is 1 W, 905 nm is 200 mW), continuous mode emission (808 nm) and pulsed mode emission (905 nm)
Study NCT02905409 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ILM peeling surgery
Description: 4PD or 2PD diameter of ILM peeling in surgery was given to patients with IMH (idiopathic macular hole)
Study NCT02905409 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ILM peeling surgery
Description: 4PD or 2PD diameter of ILM peeling in surgery was given to patients with IMH (idiopathic macular hole)
Study NCT04443478 — intervention group
Intervention type: PROCEDURE
Intervention: Radical gastrectomy with dissection of lower mediastinal lymph node
Description: Radical gastrectomy for gastric cancer should be consistent with Japanese gastric cancer treatment guideline.
Study NCT02398045 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Computerised CBT for OCD
Description: Computerised CBT for OCD
Study NCT00433017 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ranibizumab
Description: Ranibizumab 0.5 mg (0.05 mL of 10 mg/mL solution for injection) administered as an intravitreal injection
Study NCT03840265 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: carotid endarterectomy
Description: In this project the following parameters will be assessed both in asymptomatic and symptomatic patients underwent carotid endarterectomy: 1) hemodynamic modeling of effect of the supraaortic arteries anatomic variations and pathologies 2, preoperative stroke risk prediction based on comparative analysis of CTA results of plaque morphology and ultrasound-based plaque elastography analysis, 3) cerebral flow measurement by transcranial Doppler sonography(TCD), 4) presence recent of silent brain ischemia on DWI-MRI, 5) OCT angiography could be a useful non-invasive method for evaluation of the outcome of carotid interventions
Study NCT03531554 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: ketone ester drink
Description: 395 mg of ketone ester/kg
Study NCT03531554 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: exercise
Description: 35 min cycling test on an upright bicycle, followed by 10 minutes of supine cycling inside a MR scanner.
Study NCT03531554 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise
Description: 35 min cycling test on an upright bicycle, followed by 10 minutes of supine cycling inside a MR scanner.
Study NCT03531554 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: muscle biopsy
Description: biopsy from the quadriceps muscle prior to and immediately after upright bicycling
Study NCT03531554 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: muscle biopsy
Description: biopsy from the quadriceps muscle prior to and immediately after upright bicycling
Study NCT03531554 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: Magnetic Resonance Imaging
Description: 1H MR images and 31P MR spectra were acquired from the upper leg prior to-, during and after exercise
Study NCT03531554 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: 1H MR images and 31P MR spectra were acquired from the upper leg prior to-, during and after exercise
Study NCT00894504 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Panitumumab
Description: 6 mg/kg IV on Day 1 of each 2-week treatment cycle for 3 cycles (6 weeks)
Study NCT00894504 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: AUC=2.5 IV, Day 1 of each 2-week treatment cycle for 3 cycles (6 weeks)